Details of the Drug

General Information of Drug (ID: DM4LYFJ)

Drug Name

Hepatitis C immune globulin

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis C virus infection	1E51.1	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of Biotest Pharmaceuticals.